(Q44957604)

English

Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

J Delwaide

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

N Bourgeois

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

C Gérard

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

S De Maeght

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

F Mokaddem

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

E Wain

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

B Bastens

7

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

J Fevery

8

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

M Géhénot

9

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

O Le Moine

10

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

J P Martinet

11

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

G Robaeys

12

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

B Servais

13

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

M Van Gossum

14

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

H Van Vlierberghe

15

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Belgian Association for the Study of the Liver (BASL)

16

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

0 references

publication date

1 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

15-22

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02023.X

21 January 2018

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02023.X

21 January 2018

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02023.X

21 January 2018

Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02023.X

21 January 2018

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02023.X

21 January 2018

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02023.X

21 January 2018

Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02023.X

21 January 2018

Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02023.X

21 January 2018

Therapy of acute hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02023.X

21 January 2018

Effects of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study. Japan Acute Hepatitis Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02023.X

21 January 2018

Treatment of acute hepatitis C with interferon alfa-2b

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02023.X

21 January 2018

A study of susceptibility of primary human Kupffer cells to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02023.X

21 January 2018

Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02023.X

21 January 2018

When and how to treat acute hepatitis C?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02023.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2004.02023.X

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44957604&oldid=2059502366"